September 16, 2014 EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by yea

Source URL: files.shareholder.com

May 18, 2015 Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference Phase 3 Clinical Trial in Uncontrolled Persistent As

Source URL: files.shareholder.com

• Pharmacology
• Science
• Regeneron
• Asthma
• Placebo
• Clinical trial
• Medicine
• Health
• Clinical research

May 21, 2015 Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis Includes study in patients who were inadequate responders to or intolerant of

Source URL: files.shareholder.com

• Medicine
• Immunosuppressants
• Monoclonal antibodies
• Regeneron
• Rheumatoid arthritis
• Sarilumab
• Biologic
• Pharmaceutical industry
• Clinical trial
• Pharmacology
• Pharmaceutical sciences
• Health

Regeneron Black and White Logo

Source URL: www.regeneron.com

• Monoclonal antibodies
• Biology
• Anakinra
• Adalimumab
• Infliximab
• Etanercept
• Omeprazole
• TNF inhibitor
• Norfloxacin
• Medicine
• Pharmacology
• Immunosuppressants

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® (aflibercept) Injection For Intra

Source URL: www.regeneron.com

• Ranibizumab
• Vascular endothelial growth factor
• Diabetic retinopathy
• Macular edema
• Retina
• Methadone
• Macular telangiectasia
• Bevacizumab
• Medicine
• Ophthalmology
• Biology

TRADE RELEASE NOT FOR WIRE DISTRIBUTION Regeneron Hires Brian Zambrowicz, Ph.D., as Vice President of Functional Genomics and Chief of VelociGene® Operations TARRYTOWN, N.Y. AprilRegeneron Pharmaceuticals, Inc

Source URL: www.regeneron.com

• Biotechnology
• Pharmacy
• Clinical research
• Regeneron
• Monoclonal antibodies
• George Yancopoulos
• Lexicon Pharmaceuticals
• Drug discovery
• Biopharmaceutical
• Pharmaceutical sciences
• Pharmacology
• Pharmaceutical industry

ZALTRAP® (ziv-aflibercept)

Source URL: www.regeneron.com

• Chemistry
• FOLFIRI
• Irinotecan
• Medicine
• Prodrugs
• Organic chemistry
• Chemotherapy regimens

2014 Environmental Sustainability Highlights SMARTERBRIGHTERCLEANERHEALTHIER Intelligent Control

Source URL: www.regeneron.com

• Regeneron
• Carbon footprint

Thank you for completing this Regeneron Training Program! Completed by: Noboru Oshima Date:

Source URL: shibuya-hifuka.jp

March 15, 2015 Regeneron and Sanofi Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent™ (alirocumab) Published in The New England Journal of Medicine Robust and consistent LDL-C lowering demonstrated w

Source URL: files.shareholder.com

• Pharmacy
• Regeneron
• Statin
• Low-density lipoprotein
• Clinical trial
• Pharmaceutical industry
• Pharmacovigilance
• Pharmaceutical sciences
• Pharmacology
• Health